Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Actavis
|
| gptkbp:acquisitionYear |
2014
|
| gptkbp:focus |
infectious diseases
|
| gptkbp:foundedYear |
2009
|
| gptkbp:headquartersLocation |
gptkb:Chicago,_Illinois,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Durata Therapeutics
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:product |
gptkb:dalbavancin
|
| gptkbp:status |
defunct
|
| gptkbp:stockSymbol |
gptkb:DRTX
|
| gptkbp:bfsParent |
gptkb:Actavis_Generics
gptkb:dalbavancin |
| gptkbp:bfsLayer |
6
|